Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership

 
 

China Nuokang Bio-Pharmaceutical Inc. (NKBP) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $5.54 Metrics
OS: 155.9 M
Market cap: $864 M
Net cash: $189 M $1.21 per share
EV: $675 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-11Dec-31-10Dec-31-09
Revenues334.1315.8282.9
            Revenue growth5.8%11.6% 
Cost of goods sold44.637.335.6
Gross profit289.5278.5247.3
            Gross margin86.7%88.2%87.4%
Sales and marketing167.1145.5110.5
Research and development18.213.58.3
General and administrative82.553.547.6
EBITA24.466.781.4
            EBITA margin7.3%21.1%28.8%
Amortization of intangibles2.80.80.5
EBIT21.665.980.9
            EBIT margin6.5%20.9%28.6%
Pre-tax income-0.256.682.0
Income taxes-14.710.616.9
            Tax rate6270.9%18.7%20.6%
Net income-16.246.151.2
            Net margin-4.9%14.6%18.1%
 
Diluted EPS($0.10)$0.29$0.51
Shares outstanding (diluted)155.9158.899.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy